Acer Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACER Nasdaq 8731 https://acertx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Acer Therapeutics Inc

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements - Jan 31st, 2023 1:00 pm
7 Micro-Cap Stocks to Buy for Risk-Taking Investors - Jan 27th, 2023 12:05 pm
Acer Therapeutics Inc. (ACER) Gains As Market Dips: What You Should Know - Jan 25th, 2023 11:00 pm
Acer Therapeutics Inc. (ACER) Dips More Than Broader Markets: What You Should Know - Jan 19th, 2023 11:00 pm
Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics - Jan 19th, 2023 1:23 pm
5 Stocks to Buy as the Drug Industry Bets Big on Innovation - Jan 18th, 2023 1:49 pm
Are Medical Stocks Lagging Acer Therapeutics (ACER) This Year? - Jan 16th, 2023 2:40 pm
Acer Therapeutics Inc. (ACER) Stock Sinks As Market Gains: What You Should Know - Jan 10th, 2023 11:00 pm
Acer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones - Jan 9th, 2023 1:30 pm
Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate - Jan 5th, 2023 1:30 pm
Acer Therapeutics Compliant with All Nasdaq Listing Criteria - Dec 29th, 2022 1:30 pm
Acer Therapeutics Inc. (ACER) Upgraded to Strong Buy: What Does It Mean for the Stock? - Dec 28th, 2022 5:00 pm
12 Best Biotech Stocks to Buy Under $10 - Dec 28th, 2022 3:39 pm
ACER Down Despite FDA Nod for Urea Cycle Disorders Drug - Dec 28th, 2022 2:28 pm
Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders - Dec 27th, 2022 1:30 pm
UPDATE 1-U.S. FDA approves Acer Therapeutics' genetic disorder drug - Dec 23rd, 2022 7:47 pm
Is Acer Therapeutics (ACER) Stock Outpacing Its Medical Peers This Year? - Dec 13th, 2022 2:40 pm
2 Biotech Stocks Under $10 That Could Win From Key FDA Approvals - Dec 9th, 2022 2:35 am
Trade Alert: The Founder Of Acer Therapeutics Inc. (NASDAQ:ACER), Christopher Schelling, Has Just Spent US$1m Buying 43% More Shares - Dec 4th, 2022 12:17 pm
Acer Therapeutics Announces $1.5M Private Placement - Nov 30th, 2022 1:30 pm